Clinical Trials on Generalized Resistance to Thyroid Hormone in Norway
Total 34 results
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
Oslo University HospitalRecruitingQuality of Life | Thyroid Cancer | Thyroid NoduleNorway
-
University Hospital of North NorwayUniversity of Tromso; The Royal Norwegian Ministry of Health; Odd Berg Medical...CompletedHypertension, Resistant to Conventional TherapyNorway
-
Sykehuset TelemarkCompleted
-
Oslo University HospitalUnknownHypertension, Resistant to Conventional TherapyNorway
-
Oslo University HospitalHormonlaboratoriet; Spesialistsenteret Pilestredet ParkCompletedEndocrine System Diseases | Hypothyroidism | BiomarkersNorway
-
Haukeland University HospitalRecruitingThyroid-Associated OphthalmopathyNorway
-
Haukeland University HospitalCompletedThyroid-Associated OphthalmopathyNorway
-
University of OsloModum BadCompletedDepression | Generalized Anxiety | Adherence to Non-pharmacological Epidemiological Interventions (NPIs)Norway
-
Sykehuset TelemarkHelse Stavanger HF; Haukeland University HospitalCompletedHashimoto's DiseaseNorway
-
Oslo University HospitalCompletedObesity | Diabetes | Metabolic SyndromeNorway
-
Sykehuset TelemarkWithdrawn
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Genzyme, a Sanofi CompanyCompletedThyroid NeoplasmsSweden, France, Spain, Norway, Belgium, Denmark, Switzerland
-
Norwegian University of Science and TechnologySt. Olavs HospitalTerminated
-
AbbVieRecruiting
-
University of OsloThe Research Council of Norway; European CommissionCompletedMetabolic Syndrome | Type 2 DiabetesNorway
-
University of BergenKarolinska Institutet; University of Copenhagen; Technical University of Munich; University of GlasgowRecruitingHypertension | Diabetes Mellitus, Type 2 | Insulin Resistance | Glucose Intolerance | Overweight and Obesity | Dyslipidemia Associated With Type II Diabetes MellitusNorway
-
Oslo University HospitalCompletedStroke | Hypertension | Diabetes Mellitus | Ischemic Heart DiseaseNorway
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Solvay PharmaceuticalsCompletedPatients With Metabolic SyndromeHungary, Canada, Finland, Italy, Netherlands, Norway, Poland, Romania, Sweden
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Poznan University of Medical SciencesCompletedMetabolic Syndrome | Diabetes Mellitus Type 2 | Hyperlipidemia | Renal Failure Chronic Requiring HemodialysisPoland
-
Merck Sharp & Dohme LLCRecruitingCervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditionsCanada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
Eastern Cooperative Oncology GroupRecruitingMelanoma | Breast Cancer, NOS | CNS Primary Tumor, NOS | Cervical Cancer, NOS | Colorectal Cancer, NOS | Leukemia, NOS | Lymphoma, NOS | Miscellaneous Neoplasm, NOS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS | Testicular Nonseminomatous Germ Cell Tumor, NOS | Thyroid Cancer, NOS | Bone Cancer, NOSUnited States
-
AbbVieAbbVieRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditionsUnited States